期刊文献+

头痛宁胶囊对偏头痛大鼠中脑降钙素基因相关肽表达的影响 被引量:4

Effects of Toutongning Capsule on CGRP expression in the midbrain of rats with migraine headache model
下载PDF
导出
摘要 目的探讨头痛宁胶囊干预偏头痛大鼠,对模型大鼠中脑降钙素基因相关肽(CGRP)基因表达的影响,及头痛宁胶囊对内源性痛觉调制系统功能的干预作用。方法将24只健康成年Wistar大鼠随机分为对照组(A组),偏头痛组(B组),头痛宁胶囊对照组(C组),头痛宁胶囊治疗组(D组),每组6只。C、D组给予头痛宁胶囊0.375 g/(kg·d)灌胃7 d,之后B、D组大鼠制备硝酸甘油型偏头痛大鼠模型,造模2 h处死大鼠,取中脑组织。采用实时定量PCR检测各组大鼠中脑CGRP mRNA拷贝数。结果 A、B、C、D组大鼠中脑每250 ng总RNA中脑CGRP mRNA拷贝数分别为:(1.13±0.68)×104、(1.61±0.51)×104、(0.80±0.45)×104、(0.75±0.27)×104。A组与B组、C组与D组大鼠中脑CGRP mRNA拷贝数比较,差异均无统计学意义(P>0.05);C、D组大鼠中脑CGRP mRNA拷贝数明显低于B组,差异有统计学意义(P<0.05)。结论头痛宁胶囊可以降低偏头痛发作时中脑CGRP基因的表达,发挥治疗偏头痛的作用。 Objective To investigate the effects of Toutongning Capsule on Calcitonin gene-related peptide (CGRP) ex-pression in the midbrain of rats with migraine headache, and the intervention effect of Toutongning Capsule on the function of endogenous pain modulation system. Methods A total of 24 adult Wistar rats were divided into control group (group A), model group (group B), Toutongning Capsule control group (group C) and Toutongning Capsule treat-ment group (group D), with 6 rats in each group. Group C and group D were given the Toutongning Capsule 0.375 g/(kg&#183;d) for 7 days. 2 hours following nitroglycerin injection, the midbrains of rats were isolated and the expression of CGR was detected by real-time quantitative PCR. Results CGRP mRNA levels (CGRP mRNA copies per 250 ng total RNA) in the rat midbrain of group A, B, C, D were (1.13±0.68)×104, (1.61±0.51)×104, (0.80±0.45)×104, (0.75±0.27)×104 respec-tively. CGRP mRNA levels were similar between group A and group B, group C and group D, there were no significant differences in the CGRP mRNA copy number in the rat midbrain (P〉0.05). The CGRP mRNA levels were significant-ly lower in the group C and group D compared with the groups B, the difference was statistically significant (P〈0.05). Conclusion The therapeutically beneficial effects of Toutongning Capsule to migraine headaches is ralated to downreg-ulation of calcitonin gene-related peptide mRNA expressions in the midbrain.
出处 《中国医药导报》 CAS 2014年第24期12-15,共4页 China Medical Herald
基金 国家自然科学基金面上项目(编号31372267) 吉林省中医药管理局科研基金资助课题(编号2012-172)
关键词 降钙素基因相关肽 偏头痛 头痛宁胶囊 Calcitonin gene-related peptide Migraine Toutongning Capsule
  • 相关文献

参考文献17

二级参考文献41

共引文献192

同被引文献34

  • 1陈桃,郭渠莲,杨义玲.难治性偏头痛的鉴别与治疗[J].重庆医学,2013,42(16):457-458.
  • 2Goadsby PJ,SchoenenJ,Ferrari MD,et al.Towards adefi- nilion of intractable headache for use in clinical practice and trials[J].Cephalalgia,2006,26(9):1168-1170.
  • 3Schulman EA,Brahin EJ.Refractory headache:historical perspective,need,andpurposes for anoperationai definition [J].Headache,2008,48(6):770-777.
  • 4Headache classification subcom mittee of the international headiuche society.The intemational classification of headache disorders:2nd edition[J].Cephalalgia,2004,24(Suppl1):1-15.
  • 5Schulman EA,Lake III AE,Goadsby PJ,et al.Defining nifractory migraine and refractory chronic migraine:pro- poseci(,rilcria fromthe refractory headache special interest section of the americanheadache society[J],Headache,2008,48(6):778-782.
  • 6Groadshy PJ.Recent advances in understanding migraine mechanisms,molecules and Therapeutics[J].Trends Mol Med,2007,13(1):39-44.
  • 7Steinlein OK.Geneticmechanismsthat underlieepilepsy[J].Nat RevNeurosci,2004,5(5):400-408.
  • 8Silhersldn S,Saper J,Berenson F,et al.Oxcarbazepine in migraine headache:a double-blind,randomized,placebo-controlled study[J].Neurology,2008,70(7):548-555.
  • 9Chillag KL,Deroos ST.Oxcarbazepine use in paroxys- mal kinesigenic dyskinesia:report on four patients[J].Pediatr Neurol,2009,40(4):295-297.
  • 10Vikelis M,Rapoport AM.Role of antiepileptic drugs as preventive agents for migraine[J].CNS Drugs,2010,24(1):21-33.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部